|
Nucala approved to treat severe asthma
Examiner.com The FDA has approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older with a history severe attacks (exacerbations) despite receiving their current asthma medicines. |
View full post on asthma – Google News